SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

New imaging method may detect cancer earlier Will shortwave infrared be a bright spot?

Siemens AAMI 2014 CMS debate video released See a video of the debate on CMS's imaging equipment maintenance edict from December 2013

Technology uses extremely cold temperatures to treat breast cancer Multi-center trial enrolls first patients

Samsung's tablet ultrasound can diagnose patients en route to hospital The technology can prove crucial when seconds matter

Ultrasound-powered chip monitors diseases and delivers therapies May be able to study nervous system and treat Parkinson's symptoms

Celgene invests in Sequenta's MRD test Test will participate in trials to create blood cancer medicine

AFT calls for improved Ebola hospital protocols Meanwhile, 43 people in Texas are removed from Ebola watch list

Americans with insurance still not going to doctor Will making cost and quality information transparent be the solution?

Mass. health care cost transparency law underperforming Pricing still murky after transparency law introduced

FDA approves Siemens' ultrasound with true volume 3-D TEE probe The system offers real-time blood flow and valve measurements in seconds

George Morgan is vRad's new CEO.

vRad names US Oncology exec CEO

by Brendon Nafziger , DOTmed News Associate Editor
Virtual Radiologic, the country's biggest teleradiology provider, named former US Oncology executive George Morgan its new CEO.

vRad said that starting Tuesday Morgan would step in for departing CEO and president Rob Kill.

Morgan spent the last seven years as chief operating officer with US Oncology, a network of more than 1,000 cancer doctors that was bought by McKesson in 2010. During his tenure, the company's revenues doubled, growing from $1.5 billion to $3 billion, vRad said.

Before joining US Oncology, Morgan led the ambulatory surgical division of the Hospital Corporation of America, vRad said.

vRad runs a network of more than 400 radiologists and also makes workflow and image sharing and storing software. Over the past few years, it has grown quickly, having bought rival teleradiology provider Nighthawk in late 2010.

vRad's outgoing CEO Kill was with the company for five years. His LinkedIn page lists his current position as a board member on an audit committee of Uroplasty Inc., a company that makes neuromodulation products to stop incontinence.
Story Continues Below Advertisement

FDA approved successor to the PRISM 3000 XP:

MultiCam 3000eco opens new financial and diagnostic opportunities. Inter Medical of Germany and Eclipse Systems offer the most effective triple-head gamma camera on the market for heart and brain diagnostics.



"George is a highly experienced and talented leader who will help vRad achieve its next stage of growth," Eran Broshy, chair of vRad's board of directors, and a senior advisor with the company's primary sponsor, Providence Equity Partners, said in a statement. "We also thank Rob Kill...for his leadership in successfully transitioning vRad from a niche teleradiology provider to the strong market leader it is today."

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED